Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption
Compared to the medical-care group, the EVT group had significantly higher favorable outcomes (22.4% vs 0%, P = 0.021), and lower 90-day mortality (37.6% vs 65.0%, P = 0.026)
The truly useful comparison in the laboratory is therefore not "cagrilintide or semaglutide," but "amylin alone, GLP-1 alone, or both." To place these compounds among all the candidates in metabolic research, two resources are available: the comparison of retatrutide vs tirzepatide vs semaglutide and the overview of anti-obesity drugs 2026
Additionally, hair growth is gradual, and some patients may not perceive changes that are measurable under trichoscopy
